+673
London, U.K.
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Developer tools • Medical Devices (& Hospital Services) • Robotics • DeepTech • Healthcare (& Wellness) • Investment Management • Life Science • Mobility • Nanotechnology • Oncology • Consumer • Woman Focused
Founder & Managing Partner at Fuel Ventures
Fuel Ventures is a venture capital firm based in London, United Kingdom. The firm invests in companies operating in the SaaS, mobile, technology, and e-commerce sectors. The firm invests in the early and growth stage companies based in United Kingdom.
Geneva, U.S.A.
Contact this investorsSoftware (Web Marketplace Saas..) • PropTech • IT (& TMT) • Hospitality (& Events) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • Sales (& Marketing) • Entertainment (& Sports) • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Gaming (& eSports) • Analytics • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Food & Beverage • Insurance (& InsurTech) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • Healthcare (& Wellness) • Investment Management • Life Science • Mobile • Mobility • Nanotechnology • Oncology • Online Social • Consumer • Pharmaceutical (& Medicine) • Woman Focused
Index Ventures is a venture capital firm which specializes in seed, early stage, later stage and growth capital investments. The firm focuses on investing in companies based in Europe, operating in the biotechnology, retail, clean technology, media and life sciences sectors. It was founded in 1996 and is based in Geneva, Switzerland.
Index Ventures invests in multi-stage, transformative companies who are willing to challenge convention. The firm is especially dedicated to the information technology, clean technology, and life science sectors. They back the best and most ambitious entrepreneurs with a tight-knit collaborative partnership that retains a shared mission of seeing opportunity instead of obstacles. Index Ventures has teamed up with exceptional entrepreneurs in 39 cities around the world and have helped them grow into new regions. They provide a full-service partnership where they bring a lot of experience and expertise to the table.
In November 2022, they launched their second seed fund Origin II, a $300M fund focus on early-stage investing. It is $100m larger than Origin I, and is a highly collaborative fund, with seed-specific support, that works alongside solo GPs and angels, to help companies be best positioned for success.
Atlanta - San Francisco, U.S.A.
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Food & Beverage • Insurance (& InsurTech) • Logistics (& Distribution) • Material Science • Real Estate (& Construction) • Investment Management • Life Science • Mobile • Oncology • Consumer • Pharmaceutical (& Medicine) • Restaurants
Accel-KKR is a private equity firm that seeks to invest in the mid-market software and technology enabled services firms. The firm specializes in minority-growth investments to buyouts, recapitalizations and going-private transactions. It is based in Menlo Park, California and was founded in 2000.
San Francisco Bay Area (CA), U.S.A.
Contact this investorsSoftware (Web Marketplace Saas..) • Other • IT (& TMT) • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Entertainment (& Sports) • CleanTech • A.I. (& Big Data) • Cloud Services (& Infrastructure) • Developer tools • Material Science • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • Healthcare (& Wellness) • Life Science • Mobile • Mobility • Nanotechnology • Oncology • Consumer • Restaurants • Woman Focused
Mayfield Fund is a venture capital firm which specializes in seed, early stage, later stage and growth investments. It invests in companies based in the United States, Europe, India and China operating in the agribusiness, financial services, energy, data, communication, infrastructure, software, internet of things, clean energy, retail, business e-commerce and healthcare sectors. The firm was founded in 1969 and is based in Menlo Park, California.
Consumer products - Human capital - Los Angeles / Southern California - Parenting/families - Paris, France
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Media • Education • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • Cosmetics (& Fashion) • IoT (& Wearables) • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Gaming (& eSports) • Analytics • Cloud Services (& Infrastructure) • Developer tools • Insurance (& InsurTech) • Medical Devices (& Hospital Services) • Payments • Robotics • Healthcare (& Wellness) • LegalTech • Life Science • Mobile • Mobility • Nanotechnology • Oncology • Online Social • Consumer • Woman Focused
Founded in 1982 in Silicon Valley, Partech Ventures is a global investment firm with a team spread across offices in San Francisco, Paris and Berlin. Most Partners have been entrepreneurs themselves or have held management positions within tech companies. The partnership acts and invests as a single team, helping entrepreneurs build fast-growing tech and digital companies addressing large markets across multiple continents. Partech Ventures partners with entrepreneurs at the seed (Partech Entrepreneur), venture (Partech International) and/or growth (Partech Growth) stages. Companies backed by Partech Ventures have completed 21 initial public offerings and more than 50 major M&A transactions with leading international companies. Since 2012, the team has built a pioneering business development platform fostering synergies and business relationships between entrepreneurs and strategic partners.
Toronto, Canada
Contact this investorsBioTech • Hardware (& Manufacturing) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Life Science • Oncology
Founded in 2000, Genesys Capital is a venture capital firm based in Toronto, Ontario. The firm accelerates the development of companies by investing in seed, early stage, later stages. The firm invests in companies based in the United States and Canada and operating in the life sciences, biopharmaceuticals, medical devices, and healthcare service sectors.
California Paris, France,, United States
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Media • Education • Businesses Solutions • Hardware (& Manufacturing) • Insurance (& InsurTech) • Robotics • Healthcare (& Wellness) • LegalTech • Life Science • Mobile • Mobility • Nanotechnology • Oncology • Consumer
Partech is a venture capital firm headquartered in Paris, France, and spread acruss 30 countries in Europe, the US, Africa, and Asia. The firm invests tickets from 200K to 50M in B2B and B2C technologies reshaping industries. Companies backed by Partech have completed more than 21 IPOs and more than 50 strategic M&A transactions valued over $100M.
Herndon, Virginia, U.S.A.
Contact this investorsSoftware (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Businesses Solutions • Hardware (& Manufacturing) • A.I. (& Big Data) • Web Security (& Privacy) • Cloud Services (& Infrastructure) • Material Science • Medical Devices (& Hospital Services) • Mobile Apps • Healthcare (& Wellness) • Life Science • Oncology • Online Social • Pharmaceutical (& Medicine)
Founded in 2005, The Center for Innovative Technology GAP Funds is a venture capital firm headquartered in Herndon, Virginia. The firm exclusively targets seed-stage, pre-venture investment opportunities. The firm invests in the technology, life science, and cleantech sectors.
New York City, U.S.A.
Contact this investorsBioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Investment Management • Life Science • Oncology • Pharmaceutical (& Medicine)
NGN Capital is a healthcare focused venture capital firm based in New York, New York and was founded in 2003. The firm invests in companies operating in the life science, biotechnology, pharmaceutical, medical device and healthcare services sectors.
San Diego, U.S.A.
Contact this investorsIT (& TMT) • Media • HealthTech (& Fitness) • Logistics (& Distribution) • Life Science • Oncology
Forward Ventures is a venture capital firm based in San Diego, California and was founded in 1990. The firm invests in early and late stage companies operating in the life science, healthcare, pharmaceutical and medical device sectors.
San Francisco, U.S.A.
Contact this investorsBioTech • Medical Devices (& Hospital Services) • Life Science • Nanotechnology • Oncology
Amkey Ventures is a venture capital firm that identifies investment opportunities by focusing on cutting-edge biomedical technologies. The firm is based in Fremont, California and was founded in 2001.
Copenhagen, Denmark
Contact this investorsBioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Investment Management • Life Science • Oncology
Lundbeckfonden Ventures is an evergreen life science venture fund investing internationally in firms operating in the pharmaceutical, medical technology, life sciences, biotechnology, healthcare, clinical projects and diagnostics sectors. It prefers to act as a lead investor and invests in firms based in the United States and Europe. Founded in 2009, it is based in Copenhagen, Denmark and operates as a subsidiary of Lundbeckfonden.
The Oncology industry focuses on the research, diagnosis, treatment, and prevention of cancer. This includes pharmaceuticals, medical devices, diagnostics, and supportive care services aimed at improving cancer patient outcomes. The global oncology market was valued at approximately $138.1 billion in 2020 and is projected to reach $270.5 billion by 2027, growing at a CAGR of 8.9%.
The growth of this industry is driven by the increasing incidence of cancer, advancements in cancer research, and the development of innovative therapies and diagnostics. Oncology has a significant impact on society by improving survival rates, enhancing the quality of life for cancer patients, and advancing our understanding of the disease.
Pharmaceutical companies are developing targeted therapies, immunotherapies, and personalized medicine approaches that offer more effective and less toxic treatment options. These innovations provide new hope for patients and are integral to the progress in cancer treatment.
Diagnostic advancements, including liquid biopsies and genomic testing, enable earlier detection and more precise treatment planning. These technologies are crucial in improving patient outcomes and tailoring treatments to individual patient needs.
Medical devices such as advanced imaging systems and radiation therapy equipment play a critical role in diagnosing and treating cancer. These tools enhance the accuracy of diagnoses and the effectiveness of treatments, contributing to better patient care.
The COVID-19 pandemic has disrupted cancer care, with delays in screenings, diagnoses, and treatments. However, it has also accelerated the adoption of telemedicine and digital health tools, enabling remote patient monitoring and virtual consultations, which have become vital in maintaining continuity of care.
The oncology industry faces challenges related to high research and development costs, regulatory hurdles, and the need for equitable access to cutting-edge treatments. Addressing these challenges is essential to ensure that advancements benefit all patients.
As technology continues to advance, the oncology industry will play a crucial role in shaping the future of cancer care, providing innovative solutions that improve patient outcomes and enhance quality of life. Ongoing research into molecular mechanisms, novel therapeutics, and the integration of AI and big data analytics will further revolutionize the field.
The future of oncology will be defined by its ability to deliver personalized, effective, and accessible cancer care, ultimately transforming the landscape of cancer treatment and prevention. Continued investment and innovation in this sector are essential for driving growth and achieving these goals.
To connect with VCs in the Oncology sector, target firms such as Sequoia Capital, Andreessen Horowitz, and OrbiMed. Research their investment portfolios to understand their focus areas and tailor your approach accordingly.
Networking through industry conferences, oncology summits, and medical forums can provide opportunities to meet VC partners. These events offer platforms to engage with potential investors and industry experts.
When pitching, focus on demonstrating the market potential, technological innovation, and scalability of your oncology solution. Be prepared to discuss your business model, customer acquisition strategies, and revenue projections in detail to show the viability and effectiveness of your venture.
Participating in demo days hosted by medical accelerators or incubators can help you showcase your product to a broader audience of VCs. These events are excellent for gaining visibility and feedback from potential investors.
Crafting a compelling story about your product’s impact and the problem it solves will resonate well with VC investors who are looking for high-growth potential startups. Highlight the unique aspects and tangible benefits of your solution.
Following up with a comprehensive pitch deck that includes market analysis, go-to-market strategy, and potential exit opportunities can further strengthen your case. This demonstrates thorough planning and a clear path to success.
Highlighting any strategic partnerships or collaborations with major research institutions or healthcare providers can also add weight to your pitch. These relationships indicate credibility and potential for broader impact.
Ensuring that you present a well-rounded team with expertise in both oncology and business development will appeal to VCs looking for capable execution of your vision. A diverse and skilled team is critical to driving your mission forward.
Exotic Orange & Angels Partners: Turning Financial Simplicity Into Investment SuccessChatNode.ai: Revolutionizing Communication with AI, A Success StoryInterview with the Founder of ZenLaw: An Angels Partners Success Story!Sell SaaS Success StoryAWA Success StoryAngels Partners helps The MVMNT Group raise $250k for Saas productTo connect with VCs in the Oncology sector, target firms such as Sequoia Capital, Andreessen Horowitz, and OrbiMed. These firms have a strong track record of investing in successful oncology startups.
Sequoia Capital, known for backing companies like 23andMe and Guardant Health, focuses on high-growth potential and market disruption. They seek startups that can revolutionize cancer treatment and diagnostics.
Andreessen Horowitz, with investments in companies like Freenome and Tempus, looks for innovative oncology solutions that can scale globally. Their focus is on groundbreaking technologies in cancer care.
OrbiMed, a leading healthcare investment firm, seeks out startups with strong scientific foundations and significant market potential in cancer treatment and diagnostics. They aim to invest in transformative healthcare innovations.
To connect with these VCs, research their investment portfolios and identify partners who have shown interest in your industry. This targeted approach will help you find the right VCs for your oncology startup.
Attend industry conferences, oncology summits, and medical forums where these VCs are likely to be present. These events provide opportunities to network and showcase your innovations in cancer treatment.
Participating in demo days hosted by oncology tech accelerators or incubators can also provide exposure. These platforms allow you to demonstrate your startup’s potential to a wider audience.
When pitching to VCs, emphasize your startup’s market opportunity, technological innovation, and scalability. Highlight how your oncology solutions address significant challenges and have the potential to scale.
Crafting a compelling story about your product’s impact and the problem it solves will resonate well with VC investors. Focus on the unique value and advancements your oncology technology offers.
Follow up with a comprehensive pitch deck that includes market analysis, competitive landscape, and potential exit opportunities. This detailed presentation will help VCs understand your startup’s prospects.
Highlighting any strategic partnerships or collaborations with major healthcare providers or research institutions can also add weight to your pitch. These partnerships can validate your technology and enhance its credibility.
Ensuring that you present a well-rounded team with expertise in both oncology technology and business development will appeal to VCs looking for capable execution of your vision. A strong team is crucial for successful implementation and growth.
